胆固醇机制的最新进展:ISCM2022特别版的序言
Zrinka Kovarik1, Hermona Soreq2,3
1Institute for Medical Research and Occupational Health, Zagreb, Croatia.
Journal of neurochemistry
|December 12, 2023
概括
本专题号探讨了胆固醇系统,详细介绍了分子,神经化学和临床研究的进展. 它强调了系统的复杂性及其在健康和疾病中的作用,基于第17届国际胆固醇机制研讨会.
科学领域:
- 神经化学 神经化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆固醇系统在各种生理和认知功能中发挥着关键作用.
- 胆固醇机制的失调与许多神经和精神疾病有关.
- 了解胆固醇系统对于开发有效的治疗策略至关重要.
研究的目的:
- 提供关于胆固醇机制研究近期进展的全面概述.
- 巩固在第17届国际胆固醇机制研讨会 (ISCM2022) 上提出的研究.
- 突出胆固醇系统的多面性质,从分子到临床方面.
主要方法:
- 该专题刊物收录了系统评论和原创研究文章.
- 内容在很大程度上来自于在克罗地亚杜布罗夫尼克举行的ISCM2022研讨会上的演讲.
- 贡献涵盖了广泛的研究方法,包括分子,结构,神经化学,药理学和毒理学方法.
主要成果:
- 收集的作品强调了胆固醇系统的复杂性.
- 在了解分子,细胞和系统层面的胆性传播方面取得了重大进展.
- 这项研究强调了胆固醇机制对健康和疾病状态的深刻影响.
结论:
- 特别号提供了关于胆性药物研究当前状况的宝贵见解.
- 它强调了该系统在了解和治疗各种健康状况方面的相关性.
- 提出的研究结果表明了胆固醇机制的未来研究方向.
更多相关视频
相关概念视频
Direct-Acting Cholinergic Agonists: Therapeutic Uses
748
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
748
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.3K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
988
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
988
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
676
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
676
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.2K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.2K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K


